UBS Group’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-127,074
Closed -$3.97M 9986
2023
Q4
$3.97M Buy
+127,074
New +$4.57M ﹤0.01% 3027
2015
Q1
Sell
-400
Closed -$4K 9345
2014
Q4
$4K Buy
+400
New +$3.87K ﹤0.01% 9129

Other funds holding STAA

UBS Group's STAA Position: Q2 2026 in Review

UBS Group increased its STAAR Surgical (STAA) stake by 90% in Q2 2026, buying an estimated $4.48M and bringing the position to 341,183 shares worth $9.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3484.

UBS Group first reported a position in STAA in Q4 2014 and has held it in 47 quarters since. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • UBS Group held 341,183 shares of STAAR Surgical worth $9.79M as of Q2 2026.
  • UBS Group bought 161,254 STAAR Surgical shares in Q2 2026, an estimated $4.48M.
  • STAAR Surgical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3484 holding.
  • UBS Group first reported a position in STAAR Surgical in Q4 2014 and has held it in 47 quarters since.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.